Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome
about
A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains.Açai (Euterpe oleracea Mart.) Upregulates Paraoxonase 1 Gene Expression and Activity with Concomitant Reduction of Hepatic Steatosis in High-Fat Diet-Fed Rats.The relationship of nonalcoholic fatty liver disease and metabolic syndrome for colonoscopy colorectal neoplasm.Nonalcoholic Fatty Liver Disease and Associated Metabolic Risks of Hypertension in Type 2 Diabetes: A Cross-Sectional Community-Based Study.PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-β/δ and PPAR-γ.PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α.E167K polymorphism of TM6SF2 gene affects cell cycle of hepatocellular carcinoma cell HEPA 1-6.Nematodes and human therapeutic trials for inflammatory disease.Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review.NAFLD: Is There Anything New under the Sun?Nonalcoholic fatty liver disease in long-term survivors of childhood-onset craniopharyngioma.Aerobic training performed at ventilatory threshold improves liver enzymes and lipid profile related to non-alcoholic fatty liver disease in adolescents with obesity.Association Between Nonalcoholic Fatty Liver Disease and Severe Male Reproductive Organ Impairment (Germinal Epithelial Loss): Study on a Mouse Model and on Human Patients.The Eeffect of Metformin Combined with Calcium-Vitamin D3 Against Diet-Induced Nonalcoholic Fatty Liver Disease.Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjectsThe combined effect of non-alcoholic fatty liver disease and metabolic syndrome on colorectal carcinoma mortality: a retrospective in Chinese femalesFuture Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
P2860
Q31171499-866BF062-F260-422E-B5BE-085A2612C890Q37239685-EA60FFBE-100B-4A9D-BACB-66994218B8B9Q37606349-661181FA-D736-46A4-9AF1-157B29875146Q37742737-65E27F0D-4CFF-4C32-88B1-4E2BA353AB24Q38674739-62C10129-07CE-4A15-AFC3-17D6A61794CDQ38674742-2D8DC976-43A3-463F-AC73-CD0CAAF1299DQ38707814-1A48C992-7E07-4F48-BC0A-E6C42B037327Q39039247-80F5FB96-5EF5-4477-B5AC-4468C395BCFAQ41004516-4432968E-1BE1-41F8-891A-A422103DE60AQ42365749-5013A48B-2BD6-471D-95DF-CD895EFE2D2EQ42378173-B8060284-3936-45F8-BE9D-EC2D2FE99EBCQ48161470-7818FCD6-EFD8-422D-B160-EC3E02D9B491Q52631894-3DDBADBF-79DD-4343-BCBB-DC5E016D51A0Q53693877-E7877EAE-99BE-48E1-9E96-5F33F22A459AQ58722876-420BD1FF-C7DC-49C5-A930-07883E612EFBQ58790730-77CB4426-C4C8-4187-B044-4CF80D5D7BAAQ59136513-B7BEFF58-0EBB-49B0-8F2F-F87F12D15E80
P2860
Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Bidirectional Relationships an ...... ures of the Metabolic Syndrome
@ast
Bidirectional Relationships an ...... ures of the Metabolic Syndrome
@en
Bidirectional Relationships an ...... ures of the Metabolic Syndrome
@nl
type
label
Bidirectional Relationships an ...... ures of the Metabolic Syndrome
@ast
Bidirectional Relationships an ...... ures of the Metabolic Syndrome
@en
Bidirectional Relationships an ...... ures of the Metabolic Syndrome
@nl
prefLabel
Bidirectional Relationships an ...... ures of the Metabolic Syndrome
@ast
Bidirectional Relationships an ...... ures of the Metabolic Syndrome
@en
Bidirectional Relationships an ...... ures of the Metabolic Syndrome
@nl
P2860
P921
P3181
P356
P1476
Bidirectional Relationships an ...... ures of the Metabolic Syndrome
@en
P2093
Patrick Wainwright
P2860
P3181
P356
10.3390/IJMS17030367
P407
P5008
P577
2016-03-11T00:00:00Z